[2/3 COX-2 inhibitors].
Fournel
Cécile
C
Service de médecine nucléaire, CHU, Besançon.
Limat
Samuel
S
Woronoff-Lemsi
Marie-Christine
MC
D000075202:Contraindications; D052246:Cyclooxygenase 2 Inhibitors / Q000009:adverse effects* / Q000600:supply & distribution / Q000627:therapeutic use*; D004347:Drug Interactions; D005602:France; D006801:Humans; D018579:Patient Selection; D012307:Risk Factors
D052246:Cyclooxygenase 2 Inhibitors